Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
U.S. Physical Therapy, Inc. (USPH) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
U.S. Physical Therapy, Inc. (USPH) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for April 25th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 25th:
Forty Seven, Inc. : This clinical-stage immuno-oncology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
Forty Seven, Inc. Price and Consensus
Forty Seven, Inc. price-consensus-chart | Forty Seven, Inc. Quote
Forty Seven’s shares gained 10.8% over the last one month against the S&P 500’s rise of 4.6%. The company possesses a Momentum Score of B.
Forty Seven, Inc. Price
Forty Seven, Inc. price | Forty Seven, Inc. Quote
Genfit SA (GNFT - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.9% over the last 60 days.
Genfit SA Price and Consensus
Genfit SA price-consensus-chart | Genfit SA Quote
Genfit’s shares gained 15.8% over the last one month. The company possesses a Momentum Score of A.
Genfit SA Price
Genfit SA price | Genfit SA Quote
U.S. Physical Therapy, Inc. (USPH - Free Report) : This outpatient physical therapy clinics operator has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
U.S. Physical Therapy, Inc. Price and Consensus
U.S. Physical Therapy, Inc. price-consensus-chart | U.S. Physical Therapy, Inc. Quote
U.S. Physical Therapy’s shares gained 7.3% over the last one month. The company possesses a Momentum Score of A.
U.S. Physical Therapy, Inc. Price
U.S. Physical Therapy, Inc. price | U.S. Physical Therapy, Inc. Quote
SPX Corporation (SPXC - Free Report) : This infrastructure equipment supplier has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
SPX Corporation Price and Consensus
SPX Corporation price-consensus-chart | SPX Corporation Quote
SPX's shares gained 8.7% over the last one month. The company possesses a Momentum Score of B.
SPX Corporation Price
SPX Corporation price | SPX Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
See the 7 breakthrough stocks now>>